AR and neoplasm: To investigate the effect of inhibition of AR K609 acetylation on CRPC xenograft tumor growth, enzalutamide/abiraterone-resistant C4–2B cells were implanted subcutaneously in castrated male severe combined immunodeficient (SCID) mice.